Financial Summary (All financials)
In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 20,988.1 | 5,844.3 | 2,321.2 | 9.7 |
Revenue growth | 259.1% | 151.8% | 23815.3% | |
Cost of goods sold | 18,365.6 | 5,578.3 | 2,879.4 | 12.1 |
Gross profit | 2,622.6 | 266.0 | -558.1 | -2.4 |
Gross margin | 12.5% | 4.6% | -24.0% | -24.3% |
Selling, general and administrative | 9,581.8 | 4,658.4 | 1,833.2 | 959.7 |
Sales and marketing | 4,276.4 | 1,737.8 | 668.6 | 317.1 |
Research and development | 4,114.3 | 1,725.9 | 2,070.2 | 1,051.2 |
EBITA | -6,553.5 | -4,273.6 | -3,772.9 | -1,691.1 |
EBITA margin | -31.2% | -73.1% | -162.5% | -17423.1% |
Amortization of intangibles | 25.9 | 20.2 | 7.7 | 3.5 |
EBIT | -6,579.4 | -4,293.7 | -3,780.6 | -1,694.6 |
EBIT margin | -31.3% | -73.5% | -162.9% | -17459.7% |
Pre-tax income | -4,837.1 | -2,730.8 | -3,691.7 | -1,398.8 |
Income taxes | 26.0 | 1.2 | 0.0 | 0.0 |
Tax rate | | | | 0.0% |
Net income | -4,863.1 | -4,889.7 | -4,642.8 | -2,254.9 |
Net margin | -23.2% | -83.7% | -200.0% | -23231.7% |
|
Diluted EPS | ($2.96) | ($6.48) | ($13.29) | ($6.83) |
Shares outstanding (diluted) | 1,642.9 | 754.3 | 349.5 | 330.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|